Proteon Pharmaceuticals Secures 21 million Euro to Accelerate Growth
Proteon Pharmaceuticals today announced an investment of 21 million Euro to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics within
EFSA confirms safety of Bafasal®, A “First in Class”, innovative feed additive
PROTEON CONTINUES DIALOGUE WITH EU COMMISSION TO SECURE EARLY AUTHORIZATION In its first-ever evaluation of a bacteriophage feed additive, EFSA (European Food Safety Authority) concluded
Proteon Pharmaceuticals and Skretting to co-develop new phage-based solutions for aquaculture
Proteon Pharmaceuticals announced a strategic partnership with Skretting aimed at providing functional solutions to tackle health challenges in the aquaculture industry. The companies will collaborate
Proteon Pharmaceuticals announces a strategic partnership in distribution with DuPont Animal Nutrition
The partnership will bring the emerging bacteriophage technology to poultry producers to help mitigate antimicrobial resistance. Warsaw, September 9, 2020 – Proteon Pharmaceuticals, a Polish
Addressing the Superbug Concern: Phage Therapy Could Beat Drug Resistant Illnesses
In 2008, a superbug caught from a New Delhi hospital claimed the life of a Swedish patient. British scientists who found this “superbug” in New
Proteon Pharmaceuticals Joins Research Efforts to Fight Coronavirus
In response to the fight against coronavirus, Proteon Pharmaceuticals has joined the effort to create a new SARS-CoV-2 Coronavirus Detection Center in Lodz, Poland to
Proteon receives European grant to fight bacterial infections in fish farming, otherwise known as aquaculture farming.
A Łódź pharmaceutical company has received over 2 million Euros to reduce animal antibiotics in the human food chain. In an attempt to find a
Proteon Joins The U.S. Poultry & Egg Association
Proteon Pharamceuticals, a global leader in the development and commercialization of bacteriophages for industrial use in poultry farming, is now a member of the U.S.
Proteon Pharmaceuticals Awarded 2,9 mln Euro Grant for the Development of Bacteriophage Aquaculture Product
Polish biotech company Proteon Pharmaceuticals S.A, a global leader in the development and commercialization of bacteriophages for industrial use in livestock farming in poultry, dairy
Proteon receives the “Best Innovation in Aquaculture Award” at the Global Forum for Innovations in Agriculture (GFIA)
Proteon received the Best “Innovation in Aquaculture Award”, from His Excellency, Saeed Albahri Salem Alameri, and Hans van der Beek, Director General of the Abu
Proteon Founder, Professor Jarosław Dastych, presents on “Aquaculture: Challenges and Lessons of Product Development” at the Bacteriophage Therapy Summit, Boston, USA.
Proteon Founder and Board Member, Professor Jarosław Dastych, made a major presentation at the Bacteriophage Therapy Summit in Boston, USA. He spoke on the topic
Proteon Receives “2019 Animal Health Innovation Award” at the Animal Health Investment Europe Conference
Proteon Receives “2019 Animal Health Innovation Award” at the Animal Health Investment Europe Conference in London, UK.. COO and Board Member Matthew Tebeau accepted the
Proteon Pharmaceuticals is Fighting Salmonella by Attacking it on the Farm
Proteon Pharmaceuticals COO Matthew Tebeau sat down with Christine Corrado from Proactive Investors at the 11th Annual BioTech Showcase in San Francisco. The Poland-based biotech
Proteon Pharmaceuticals gives an extensive comment on Salmonella issue in Poland in a video interview for a Polish business wire agency
Proteon Pharmaceuticals today announced an investment of 21 million Euro to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics within
Proteon Pharmaceuticals was invited to present its bacteriophage technology at the prestigious animal nutrition conference FIAAP in Bangkok
Proteon Pharmaceuticals was an invited speaker at the 9th edition of the FIAAP Animal Nutrition conference held on March 27, 2018 in Bangkok, Thailand. This
Proteon Pharmaceuticals attracts environmental impact investment fund
Proteon Pharmaceuticals S.A., a Polish biotechnology firm has signed an agreement with an international Investment Fund, the Aqua-Spark fund, which invests in sustainable aquaculture. Proteon
BAFADOR® presented at the international bacteriophage conference in Tbilisi
Proteon Pharmaceuticals presents its unique product BAFADOR® at the international bacteriophage conference in Tbilisi Proteon Pharmaceuticals participated in the international conference “Centennial Celebration of Bacteriophage
Proteon Pharmaceuticals awarded grants for Euro 3.2 m
In 2016 Proteon Pharmaceuticals awarded grants from Polish Center for Research & Development for Euro 3.2 m In 2016, Proteon Pharmaceuticals signed the agreements for